By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pharmacogenomic testing startup Foundation Medicine has raised $25 million in a round of Series A financing led by Third Rock Ventures, the Cambridge, Mass.-based firm said today.

The venture financing will be used to develop clinical lab tests that will analyze tumor genomic and other molecular information in individual patients' cancers and link it to a base of clinical oncology data that can help physicians tailor their treatments, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.